Dr Olivia Ngan has a multidisciplinary background in neuroscience (BS, University in Michigan – Ann Arbor), bioethics (MS, Columbia University), and public health (PhD, Chinese University of Hong Kong). Her primary research work explores ethical issues in the translational application of emerging technologies in genomic medicine and healthcare services, including reproductive technologies (e.g. surrogacy and social egg freezing), prenatal screening and diagnosis, and newborn screening). In her doctoral work, she employed a mixed-method study, looking at the public health and social implications of non-invasive parental test screening for chromosomal aneuploidy in the two-tiered healthcare system. At present, she is collaborating with Hong Kong Children’s Hospital to explore public receptivity towards the storage of dried blood spot cards and whole-genome sequencing newborn screening. She is also interested in examining how the pandemic exacerbates health issues among vulnerable populations. Over the years, she has authored books and published papers in international peer-reviewed journals in public health, healthcare research, ethics, and medical education.